Literature DB >> 21538997

Trafficking of drug candidates relevant for sports drug testing: detection of non-approved therapeutics categorized as anabolic and gene doping agents in products distributed via the Internet.

Mario Thevis1, Hans Geyer, Andreas Thomas, Wilhelm Schänzer.   

Abstract

Identifying the use of non-approved drugs by cheating athletes has been a great challenge for doping control laboratories. This is due to the additional complexities associated with identifying relatively unknown and uncharacterized compounds and their metabolites as opposed to known and well-studied therapeutics. In 2010, the prohibited drug candidates and gene doping substances AICAR and GW1516, together with the selective androgen receptor modulator (SARM) MK-2866 were obtained by the Cologne Doping Control Laboratory from Internet suppliers and their structure, quantity, and formulation elucidated. All three compounds proved authentic as determined by liquid chromatography-high resolution/high accuracy (tandem) mass spectrometry and comparison to reference material. While AICAR was provided as a colourless powder in 100 mg aliquots, GW1516 was obtained as an orange/yellow suspension in water/glycerol (150 mg/ml), and MK-2866 (25 mg/ml) was shipped dissolved in polyethylene glycol (PEG) 300. In all cases, the quantified amounts were considerably lower than indicated on the label. The substances were delivered via courier, with packaging identifying them as containing 'amino acids' and 'green tea extract', arguably to circumvent customs control. Although all of the substances were declared 'for research only', their potential misuse in illicit performance-enhancement cannot be excluded; moreover sports drug testing authorities should be aware of the facile availability of black market copies of these drug candidates.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21538997     DOI: 10.1002/dta.283

Source DB:  PubMed          Journal:  Drug Test Anal        ISSN: 1942-7603            Impact factor:   3.345


  6 in total

Review 1.  From gene engineering to gene modulation and manipulation: can we prevent or detect gene doping in sports?

Authors:  Giuseppe Fischetto; Stéphane Bermon
Journal:  Sports Med       Date:  2013-10       Impact factor: 11.136

2.  Identification of black market products and potential doping agents in Germany 2010-2013.

Authors:  Oliver Krug; Andreas Thomas; Katja Walpurgis; Thomas Piper; Gerd Sigmund; Wilhelm Schänzer; Tim Laussmann; Mario Thevis
Journal:  Eur J Clin Pharmacol       Date:  2014-08-30       Impact factor: 2.953

Review 3.  Adenosine Monophosphate-activated Protein Kinase (AMPK) Activators For the Prevention, Treatment and Potential Reversal of Pathological Pain.

Authors:  Theodore J Price; Vaskar Das; Gregory Dussor
Journal:  Curr Drug Targets       Date:  2016       Impact factor: 3.465

Review 4.  Anabolic agents: recent strategies for their detection and protection from inadvertent doping.

Authors:  Hans Geyer; Wilhelm Schänzer; Mario Thevis
Journal:  Br J Sports Med       Date:  2014-03-14       Impact factor: 13.800

5.  Detection of β-methylphenethylamine, a novel doping substance, by means of UPLC/MS/MS.

Authors:  Piotr Chołbiński; Mariola Wicka; Katarzyna Kowalczyk; Anna Jarek; Paweł Kaliszewski; Andrzej Pokrywka; Ewa Bulska; Dorota Kwiatkowska
Journal:  Anal Bioanal Chem       Date:  2014-03-16       Impact factor: 4.142

6.  Body Builder's Nightmare: Black Market Steroid Injection Gone Wrong: a Case Report.

Authors:  Or Friedman; Ehud Arad; Oded Ben Amotz
Journal:  Plast Reconstr Surg Glob Open       Date:  2016-09-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.